- Home
- KORE vs TPST Comparison
KORE vs TPST Comparison
Compare KORE & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- TPST
- Stock Information
- Founded
- KORE 2003
- TPST 2011
- Country
- KORE United States
- TPST United States
- Employees
- KORE N/A
- TPST N/A
- Industry
- KORE Telecommunications Equipment
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- TPST Health Care
- Exchange
- KORE Nasdaq
- TPST Nasdaq
- Market Cap
- KORE 39.3M
- TPST 33.0M
- IPO Year
- KORE N/A
- TPST N/A
- Fundamental
- Price
- KORE $2.35
- TPST $6.86
- Analyst Decision
- KORE Hold
- TPST Hold
- Analyst Count
- KORE 2
- TPST 3
- Target Price
- KORE $2.75
- TPST $30.00
- AVG Volume (30 Days)
- KORE 14.4K
- TPST 247.2K
- Earning Date
- KORE 08-14-2025
- TPST 08-07-2025
- Dividend Yield
- KORE N/A
- TPST N/A
- EPS Growth
- KORE N/A
- TPST N/A
- EPS
- KORE N/A
- TPST N/A
- Revenue
- KORE $282,254,000.00
- TPST N/A
- Revenue This Year
- KORE $4.66
- TPST N/A
- Revenue Next Year
- KORE $6.71
- TPST N/A
- P/E Ratio
- KORE N/A
- TPST N/A
- Revenue Growth
- KORE N/A
- TPST N/A
- 52 Week Low
- KORE $1.10
- TPST $5.35
- 52 Week High
- KORE $4.88
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- KORE 47.41
- TPST 49.91
- Support Level
- KORE $2.20
- TPST $6.87
- Resistance Level
- KORE $2.50
- TPST $7.25
- Average True Range (ATR)
- KORE 0.18
- TPST 0.67
- MACD
- KORE -0.02
- TPST -0.02
- Stochastic Oscillator
- KORE 47.76
- TPST 11.20
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.